Your browser doesn't support javascript.
loading
Validation of a non-laboratorial questionnaire to identify Metabolic Syndrome among a population in central Mexico.
Porchia, Leonardo M; Lara-Solis, Beatriz; Torres-Rasgado, Enrique; Gonzalez-Mejia, M Elba; Ruiz-Vivanco, Guadalupe; Pérez-Fuentes, Ricardo.
Afiliação
  • Porchia LM; Independent researcher and consultant. Laboratorio de Investigación en Fisiopatología de Enfermedades Crónicas, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla, Mexico.
  • Lara-Solis B; Independent researcher and consultant. Laboratorio de Investigación en Fisiopatología de Enfermedades Crónicas, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Puebla, Mexico.
  • Torres-Rasgado E; Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
  • Gonzalez-Mejia ME; Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
  • Ruiz-Vivanco G; Programa de Ciencias Biológicas, Centro Tlaxcala de Biología de la Conducta, Universidad Autónoma de Tlaxcala, Tlaxcala, Mexico.
  • Pérez-Fuentes R; Facultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, Mexico.
Article em En | MEDLINE | ID: mdl-31093233
ABSTRACT

OBJECTIVE:

To determine the reliability of a non-laboratorial questionnaire, the Encuesta de Identificación de Sujetos Metabólicamente Comprometidos en Fase-I (ESF-I) for identifying Metabolic Syndrome among a population in central Mexico.

METHODS:

Clinical and biochemical parameters were collected for 232 participants from 1 June 2012 - 31 August 2013. Three definitions of Metabolic Syndrome (Harmonizing, National Cholesterol Education Program Expert Panel and Adult Treatment Panel III [ATPIII], and International Diabetes Federation [IDF]) were used to allocate subjects to either the normal or Metabolic Syndrome positive (MetS+) group. The predictability of the questionnaire was determined by the Area-Under-the-Receiver-Operating Characteristic curve (AUC). Youden's index was calculated and the highest score was considered the optimal cutoff value. Cohen´s kappa (κ) was calculated to determine the level of agreement between the ESF-I questionnaire (max score 15 based on 15 items) and Metabolic Syndrome.

RESULTS:

From 53.8% - 60.7% of the participants were determined to be MetS+. The average questionnaire score was significantly higher in the MetS+ group for each definition (4.0 vs. 8.0, P < 0.05). The ESF-I questionnaire was predictive for the Harmonizing definition (AUC = 0.841, 95%CI 0.790 - 0.892), the ATPIII definition (AUC = 0.827, 95%CI 0.774 - 0.880), and the IDF definition (AUC = 0.836, 95%CI 0.785 - 0.887). A cutoff value of 7 was determined for each definition; therefore, the cohort was re-categorized based on questionnaire results. There was a strong agreement between the ESF-I questionnaire and MetS (Harmonizing accuracy = 77.6%, κ = 0.554; ATPIII accuracy = 74.1%, κ = 0.489; IDF accuracy = 74.6%, κ = 0.495, P < 0.001).

CONCLUSION:

The ESF-I questionnaire can identify MetS+ patients, and therefore, lead to earlier diagnoses, reduced number of consultations, and lower costs with easier application.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies País/Região como assunto: Mexico Idioma: En Revista: Rev Panam Salud Publica Assunto da revista: SAUDE PUBLICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies País/Região como assunto: Mexico Idioma: En Revista: Rev Panam Salud Publica Assunto da revista: SAUDE PUBLICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA